Generic Fenoglide for High Cholesterol Launched by Mylan


Mylan is releasing a generic version of Santarus' fenofibrate (Fenoglide) tablets.

Mylan is releasing a generic version of Santarus’ fenofibrate (Fenoglide) tablets.

The FDA approved the manufacturer’s abbreviated new drug application for the 40-mg and 120-mg tablets on July 6, 2016.

The product may be used as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total cholesterol, triglycerides, and apolipoprotein B and to increase high-density lipoprotein in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

In the year ending April 30, 2016, fenofibrate tablets had US sales of around $28.6 million, IMS Health reported.

Mylan hopes to receive FDA approval for nearly 250 additional abbreviated new drug applications still pending.

Related Videos
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская |
cropped view of man performing chest compression on dummy during cpr training class - Image credit: LIGHTFIELD STUDIOS |
Medicine law concept. Judges gavel with pills | Image Credit: Iren Moroz -
Image credit: New Africa |
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages -
Image credit: alicja neumiler |
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image Credit: Pixel-Shot |
© 2024 MJH Life Sciences

All rights reserved.